SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-055012
Filing Date
2020-10-16
Accepted
2020-10-16 12:08:37
Documents
1
Period of Report
2020-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8393
  Complete submission text file 0001209191-20-055012.txt   10018
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 AVENUE D'OUCHY C/O HEALTHCAP VIII GP SA CH 1006 LAUSANNE V8 1006
Business Address 18 AVENUE D'OUCHY C/O HEALTHCAP VIII GP SA CH 1006 LAUSANNE V8 1006 41-21-614 35 00
HealthCap VIII, L.P. (Reporting) CIK: 0001783281 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39594 | Film No.: 201243368